Indeed, and there's been much discussion that the chemistry that makes Lunesta patentable is trivial, basically a patent for its own sake.
"a single isomer drug rarely offers a therapeutic advantage over the mixture of isomers from which it is derived. However, the single isomer is patentable distinct from its multiple-isomer origin. Thus, the drug company can get a monopoly."
"a single isomer drug rarely offers a therapeutic advantage over the mixture of isomers from which it is derived. However, the single isomer is patentable distinct from its multiple-isomer origin. Thus, the drug company can get a monopoly."
http://insomnia-relief.com/information/?p=49